Showing results (471-480 of 861) with videos related to
Sort By:
Pageof 87
Psychological Medicine|March 11, 2024
Pain sensitivity as a state marker and predictor for adolescent non-suicidal self-injuryHan-Tin Kao, Ines Mürner-Lavanchy, Elisabeth von Stosch, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 28, 2023
Mobile health interventions in multiple sclerosis: A systematic reviewChristoph Heesen, Thomas Berger, Karin Riemann-Lorenz, et al.Journal of Consulting and Clinical Psychology|May 4, 2026
Alliance in internet-based interventions: A systematic review and correlation multilevel meta-analysisChristoph Flückiger, Anna-Marie Schweizer, Madita-Sophie Boehme, et al.Multiple Sclerosis and Related Disorders|August 7, 2022
MR imaging in children with transverse myelitis and acquired demyelinating syndromesInes El Naggar, Robert Cleaveland, Eva-Maria Wendel, et al.Digital Health|July 18, 2022
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trialPatrick Altmann, Fritz Leutmezer, Markus Ponleitner, et al.Life Sciences in Space Research|July 17, 2015
Constitutive expression of tdTomato protein as a cytotoxicity and proliferation marker for space radiation biologyArif A Chishti, Christine E Hellweg, Thomas Berger, et al.European Journal of Neurology|September 26, 2020
Multiple sclerosis and COVID-19: How many are at risk?Gabriel Bsteh, Christina Bitschnau, Harald Hegen, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2014
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literatureFranziska Di Pauli, Thomas Berger, Alois Walder, et al.Journal of Neurology|June 12, 2026
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment RegistryMichael Guger, Christian Enzinger, Bettina Heschl, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseRomana Höftberger, María Sepulveda, Thaís Armangue, et al.Pageof 87